These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29073585)

  • 21. Estimation of population pharmacokinetic parameters of free-phenytoin in adult epileptic patients.
    Deleu D; Aarons L; Ahmed IA
    Arch Med Res; 2005; 36(1):49-53. PubMed ID: 15777995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentration of antiepileptic drugs in persons with epilepsy: a comparative study in serum and saliva.
    Dwivedi R; Singh M; Kaleekal T; Gupta YK; Tripathi M
    Int J Neurosci; 2016 Nov; 126(11):972-8. PubMed ID: 26441313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spotlight on the continual applicability of routine plasma monitoring antiepileptic drugs in the treatment of epilepsy.
    El Desoky E; Kandil MR; Afifi AH; Mostafa OA
    Pharmacol Res; 1999 Apr; 39(4):269-74. PubMed ID: 10208756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum phenytoin concentrations in paediatric patients following intravenous loading.
    Hawcutt DB; Sampath S; Timmis A; Newland V; Newland P; Appleton R
    Arch Dis Child; 2011 Sep; 96(9):883-4. PubMed ID: 21596726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
    Fukuoka N; Uno J; Tsukamoto T; Houchi H; Kimura M; Morita S
    Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fosphenytoin: pharmacokinetics and tolerance of intramuscular loading doses.
    Pryor FM; Gidal B; Ramsay RE; DeToledo J; Morgan RO
    Epilepsia; 2001 Feb; 42(2):245-50. PubMed ID: 11240597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of plasma unbound drug concentrations in adjusting phenytoin doses.
    Bachmann K; Voeller K; Forney R
    Ther Drug Monit; 1984; 6(2):173-8. PubMed ID: 6740736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population Pharmacokinetic Analysis of Phenytoin After Intravenous Administration of Fosphenytoin in Adult and Elderly Epileptic Patients.
    Higuchi K; Yamashita D; Kashihara Y; Kakara M; Hirota T; Hirakawa M; Ieiri I
    Ther Drug Monit; 2019 Oct; 41(5):674-680. PubMed ID: 31095070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosing accuracy of antiepileptic drug regimens as determined by serum concentrations in outpatient epilepsy clinic patients.
    Privitera MD
    Ther Drug Monit; 1989 Nov; 11(6):647-51. PubMed ID: 2595745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of central brain (cerebrospinal and extracellular fluids) and peripheral blood kinetics of phenytoin after intravenous phenytoin and fosphenytoin.
    Wang X; Patsalos PN
    Seizure; 2003 Sep; 12(6):330-6. PubMed ID: 12915078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of D-cycloserine on the anticonvulsant activity of phenytoin and carbamazepine against electroconvulsions in mice.
    Wlaź P; Roliński Z; Czuczwar SJ
    Epilepsia; 1996 Jul; 37(7):610-7. PubMed ID: 8681892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy.
    Epilepsia; 1998 Sep; 39(9):952-9. PubMed ID: 9738674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical Care Management of Status Epilepticus at a Tertiary Care University Hospital.
    Mahmoud SH; Marette V; Lindqvist T; Ahmed SN
    Can J Neurol Sci; 2019 Nov; 46(6):702-710. PubMed ID: 31554529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of therapeutic drug monitoring of antiepileptic drugs.
    Irshaid YM; Hamdi AA; Al Homrany M
    Int J Clin Pharmacol Ther; 2003 Mar; 41(3):126-31. PubMed ID: 12665161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy.
    Ortega-Vázquez A; Dorado P; Fricke-Galindo I; Jung-Cook H; Monroy-Jaramillo N; Martínez-Juárez IE; Familiar-López I; Peñas-Lledó E; LLerena A; López-López M
    Pharmacogenomics J; 2016 Jun; 16(3):286-92. PubMed ID: 26122019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of phenytoin therapy in adults with epilepsy in the Western Cape, South Africa.
    Valodia PN; Seymour MA; Kies BM; Folb PI
    J Clin Pharm Ther; 1999 Oct; 24(5):381-5. PubMed ID: 10583702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Derivation and evaluation of an equation for prediction of free phenytoin concentration in patients co-medicated with valproic acid.
    Haidukewych D; Rodin EA; Zielinski JJ
    Ther Drug Monit; 1989; 11(2):134-9. PubMed ID: 2497562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy.
    Kong ST; Lim SH; Lee WB; Kumar PK; Wang HY; Ng YL; Wong PS; Ho PC
    PLoS One; 2014; 9(9):e108190. PubMed ID: 25255292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute oral loading of carbamazepine-CR and phenytoin in a double-blind randomized study of patients at risk of seizures.
    Van Der Meyden CH; Kruger AJ; Müller FO; Rabie W; Schall R
    Epilepsia; 1994; 35(1):189-94. PubMed ID: 8112244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.